Philip Morris International Stock: Shares Fall 3.83% Despite Better-than-Expected Quarterly Results
Philip Morris International closed down 3.83% at $152.00 on October 21, 2025, amidst the release of strong quarterly results. The tobacco giant revealed its third-quarter accounts and raised its annual forecasts for the third time this year, yet the market responded cautiously after a day marked by erratic movements. Nevertheless, the stock has shown a 27.77% increase over the past twelve months, significantly outperforming the S&P 500, which gained 18.33% over the same period.
Stock Performance on Release Day
Philip Morris International's stock ended the session on October 21 at $152.00, dropping 3.83% from the previous close. This decline occurred while the S&P 500 index rose by 0.36% on the same day, highlighting the stock's relative underperformance. Trading volumes were particularly high with 28.15 million shares exchanged, representing 1.81% of the company's market capitalization. This capital turnover reflects intense activity around the stock during this earnings release session. Over the week, the stock fell by 4.44%, marking a consolidation phase after a largely positive year. However, the stock still maintains a comfortable lead of 27.77% over twelve months, demonstrating sustained investor interest in the stock. This annual performance exceeds that of the S&P 500 by nearly ten points, positioning Philip Morris among the large-cap stocks that have best withstood a mixed market environment. The day of October 21 was characterized by unusual volatility, with significant price fluctuations early in the session before stabilizing in negative territory.
Third Quarter 2025 Financial Results
Philip Morris International reported its third-quarter 2025 results, posting an adjusted earnings per share of $2.24, up 17.3% year-over-year and significantly above the analyst consensus of $2.09. Quarterly revenues reached $10.8 billion, surpassing estimates of $10.69 billion, with organic growth of 5.9% driven primarily by smoke-free products which jumped 13.9%. Operating profit increased by 16.7% to $4.3 billion. With these strong performances, the tobacco company raised its adjusted earnings per share range for the full year 2025, now between $7.46 and $7.56 compared to previously $7.43 to $7.56, implying a year-over-year increase of 13.5% to 15.1%. CEO Jacek Olczak highlighted that the global portfolio of smoke-free products is growing significantly faster than the industry, with positive total volumes and expanding margins. This momentum is largely driven by strong demand for the Zyn nicotine pouch and the IQOS inhalable device, which offset the structural decline of traditional cigarette brands like Marlboro and Chesterfield. Despite these encouraging results, the session was marked by a mixed market reaction, with the stock initially dropping 6% early in the morning before rebounding in pre-opening, to eventually close down by 3.83%.
